Screening & Diagnosis
Information about breast cancer screening tests and tests used during the work up of a new diagnosis.
Your Breast Cancer Diagnosis Form
Use this form to collect information about your breast cancer diagnosis.
A mammogram is an imaging test that takes x-rays of the breasts to screen for breast cancer.
Digital Breast Tomosynthesis (3D Mammography)
Breast tomosynthesis, or 3D mammography, is a technique using X-rays to produce a three-dimensional picture of the breast. This method results in fewer callbacks, repeat testing and biopsies and is also better able to detect cancers than traditional 2D mammogram.
An MRI of the breast can give healthcare providers more facts about breast health that cannot be seen on mammogram or ultrasound and is used along with mammogram for breast cancer screening.
Breast Imaging, Reporting & Data System (BIRADS)
The Breast Imaging Data Reporting System (BI-RADS®) is a way to standardize how mammogram results are reported by radiologists and the BI-RADS score may be included in your mammogram report.
Understanding Your Pathology Report: Breast Cancer
An overview of the information you may find in your breast pathology report and what it means for you.
Molecular Testing for Breast Cancer
When breast cancer is diagnosed, the tumor tissue is tested for several “biomarkers”, which are substances or abnormalities that can be detected in the tumor tissue and used to predict prognosis and guide treatment recommendations.
Triple-Negative Breast Cancer
This article provides an overview of triple-negative breast cancer, its diagnosis, and treatment.
HER2 Positive Breast Cancer
This article explains what HER2 positive breast cancer is, including how it is diagnosed and treated.
Hormone Receptor (HR) Positive Breast Cancer
This article provides an overview of hormone receptor-positive breast cancer, diagnosis, and treatment.
The Oncotype® DX Breast Recurrence Score
This article provides an overview of the Oncotype® DX Breast Recurrence Score and its use in treatment planning for HR+/HER2- breast cancers.